Kalpit Patel Analyst PerformanceAnalyst at Wolfe ResearchKalpit Patel is a stock analyst at Wolfe Research in the healthcare sector, covering 28 publicly traded companies. Over the past year, Kalpit Patel has issued 39 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Kalpit Patel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kalpit Patel's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 4 YearsBuy Recommendations63.04% 29 Buy RatingsCompanies Covered28 Unique Companies Ratings Distribution46RatingsDistribution of strong buy, buy, hold, and sell ratings by Kalpit Patel.RatingPercentageCount Strong Buy8.7%4 ratings Buy54.3%25 ratings Hold32.6%15 ratings Sell4.3%2 ratingsOut of 46 total stock ratings issued by Kalpit Patel at Wolfe Research, the majority (54.3%) have been Buy recommendations, followed by 32.6% Hold, 8.7% Strong Buy, and 4.3% Sell.Best & Worst CallsBest Call000.0%KYMRJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%GERNFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ28 companiesKalpit Patel, an analyst at Wolfe Research, currently covers 28 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare28 companies100.0%Kalpit Patel of Wolfe Research specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY25 companies89.3%PHARMACEUTICALS3 companies10.7% Kalpit Patel's Ratings History at Wolfe Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTSHATaysha Gene Therapies9/17/2026Initiated Coverage$5.07Outperform$0.0000.00% ROIVSTMVerastem9/17/2026Initiated Coverage$7.32Outperform$0.0000.00% ROIZYMEZymeworks9/17/2026Initiated Coverage$26.24Outperform$0.0000.00% ROIJANXJanux Therapeutics8/24/2026Upgrade$17.39$23.00Outperform$0.0000.00% ROIONCBeOne Medicines8/10/2026Reiterated Rating$357.66$370.00Outperform$0.0000.00% ROICORTCorcept Therapeutics7/27/2026Downgrade$95.36$50.00Underperform$0.0000.00% ROIKYMRKymera Therapeutics6/29/2026Boost Price Target$106.80$155.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals5/19/2026Initiated Coverage$95.49$145.00Outperform$0.0000.00% ROICGONCG Oncology5/19/2026Initiated Coverage$62.93Peer Perform$0.0000.00% ROITYRATyra Biosciences5/19/2026Initiated Coverage$35.66Peer Perform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MIRMMirum Pharmaceuticals5/19/2026Initiated Coverage$95.65$145.00Outperform$0.0000.00% ROISLNOSoleno Therapeutics4/7/2026Downgrade$52.26Hold$0.0000.00% ROIGMABGenmab A/S3/27/2026Initiated Coverage$26.03$32.00Outperform$0.0000.00% ROIOLMAOlema Pharmaceuticals3/27/2026Initiated Coverage$14.12Peer Perform$0.0000.00% ROIKRYSKrystal Biotech3/27/2026Initiated Coverage$251.40Peer Perform$0.0000.00% ROIONCBeOne Medicines3/27/2026Initiated Coverage$276.95$340.00Outperform$0.0000.00% ROICORTCorcept Therapeutics3/26/2026Upgrade$40.47Peer Perform$0.0000.00% ROIAVBPArriVent BioPharma3/23/2026Boost Price Target$22.22$45.00Buy$0.0000.00% ROICELCCelcuity3/12/2026Reiterated Rating$109.43$110.00Outperform$0.0000.00% ROIASNDAscendis Pharma A/S3/2/2026Reiterated Rating$236.07$260.00Outperform$0.0000.00% ROISLNOSoleno Therapeutics1/12/2026Set Price Target$41.50$60.00$0.0000.00% ROISLNOSoleno Therapeutics1/12/2026Reiterated Rating$41.57Outperform$0.0000.00% ROICORTCorcept Therapeutics12/31/2025Downgrade$36.05$30.00Underperform$0.0000.00% ROIKYMRKymera Therapeutics12/22/2025Boost Price Target$83.99$117.00Buy$0.0000.00% ROIPDSBPDS Biotechnology11/25/2025Lower Price Target$0.75$3.00Buy$0.0000.00% ROITNGXTango Therapeutics11/18/2025Initiated Coverage$7.98Peer Perform$0.0000.00% ROISMMTSummit Therapeutics11/18/2025Initiated Coverage$16.95Peer Perform$0.0000.00% ROISLNOSoleno Therapeutics11/18/2025Initiated Coverage$47.25$75.00Outperform$0.0000.00% ROISRRKScholar Rock11/18/2025Initiated Coverage$36.47$42.00Outperform$0.0000.00% ROIRVMDRevolution Medicines11/18/2025Initiated Coverage$69.14$75.00Outperform$0.0000.00% ROIORICOric Pharmaceuticals11/18/2025Initiated Coverage$12.06Peer Perform$0.0000.00% ROIJANXJanux Therapeutics11/18/2025Initiated Coverage$28.72Peer Perform$0.0000.00% ROICORTCorcept Therapeutics11/18/2025Initiated Coverage$75.12Peer Perform$0.0000.00% ROICELCCelcuity11/18/2025Initiated Coverage$92.23$110.00Outperform$0.0000.00% ROIACLXArcellx11/18/2025Initiated Coverage$90.34Peer Perform$0.0000.00% ROICELCCelcuity11/17/2025Upgrade$94.23Strong-Buy$0.0000.00% ROIRVMDRevolution Medicines11/17/2025Upgrade$70.53Strong-Buy$0.0000.00% ROISLNOSoleno Therapeutics11/17/2025Upgrade$47.00Strong-Buy$0.0000.00% ROISRRKScholar Rock11/17/2025Upgrade$39.69Strong-Buy$0.0000.00% ROIKYMRKymera Therapeutics6/3/2025Upgrade$43.13$60.00Buy$00.0000.00% ROITrump's New Dollar (Ad)Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.Watch the free briefing and see the three steps to prepare todayBCYCBicycle Therapeutics5/2/2025Lower Price Target$9.19$14.00Neutral$0.0000.00% ROIAVBPArriVent BioPharma3/20/2025Initiated Coverage$19.60$37.00Buy$00.0000.00% ROIRIGLRigel Pharmaceuticals3/5/2025Boost Price Target$19.49$24.00Neutral$00.0000.00% ROIGERNGeron2/18/2025Lower Price Target$2.63$3.50Buy$0.0000.00% ROIVSTMVerastem1/31/2025Boost Price Target$6.39$9.00Buy$0.0000.00% ROIFHTXFoghorn Therapeutics1/30/2025Initiated Coverage$3.98$10.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
